ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 72 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,040,748 | -21.5% | 1,163,760 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $8,971,414 | +69306.0% | 1,156,110 | -49.0% | 0.00% | -42.9% |
| Q1 2023 | $12,926 | +16.5% | 2,267,642 | +20.4% | 0.01% | +16.7% |
| Q4 2022 | $11,097 | -99.8% | 1,883,978 | +23.2% | 0.01% | +100.0% |
| Q3 2022 | $4,892,000 | -24.3% | 1,528,608 | +6.0% | 0.00% | -25.0% |
| Q2 2022 | $6,460,000 | +220.4% | 1,441,977 | +282.0% | 0.00% | +300.0% |
| Q1 2022 | $2,016,000 | -50.8% | 377,491 | +62.8% | 0.00% | -66.7% |
| Q2 2021 | $4,101,000 | +35.6% | 231,853 | +87.8% | 0.00% | +50.0% |
| Q1 2021 | $3,025,000 | -12.3% | 123,457 | +21.2% | 0.00% | 0.0% |
| Q4 2020 | $3,448,000 | +463.4% | 101,862 | +315.9% | 0.00% | +100.0% |
| Q3 2020 | $612,000 | – | 24,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |